Thank you Quynh Vu for your excellent overview of the STOPAH trial (Prednisolone or Pentoxifylline for Alcoholic Hepatitis)
Conclusions of the study:
- Pentoxifylline did not improve survival in patients with alcoholic hepatitis
- Prednisolone was associated with a reduction in 28-day mortality that did not reach significance and with no improvement in outcomes at 90 days or 1 year
Main points: STOPAH PowerPoint
Read Full Article: STOPAH Trial
No Url Found